Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Proteon Appoints Regulatory Affairs VP | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Proteon Appoints Regulatory Affairs VP

Panagoulias to oversee U.S. and international regulatory matters

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Jennifer Panagoulias has been appointed vice president of Regulatory Affairs at Proteon Therapeutics. Ms. Panagoulias will oversee all aspects of regulatory affairs, providing oversight for U.S. and international regulatory matters, including filings and interactions with regulatory authorities.
 
She joins the company from Alnylam Pharmaceuticals, where she was senior director of Regulatory Affairs. Prior to Alnylam, she held positions of increasing responsibility at Genzyme, rising to global therapeutic head, Regulatory Affairs Neurology following Sanofi’s acquisition of Genzyme.
 
“We are pleased to have Jennifer join our team. Her proven track record in U.S. and international regulatory affairs for global biotechnology franchises will be invaluable to Proteon,” said Timothy Noyes, President and Chief Executive Officer. “Jennifer will play a pivotal role in the late stage clinical development and potential regulatory filing and approval of Proteon’s lead product candidate, vonapanitase.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics